The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients

The treatment for chronic active antibody-mediated rejection (CAMR) remains controversial. We investigated the efficacy of rituximab (RTX) and intravenous immunoglobulin (IVIg) for CAMR. Eighteen patients with CAMR were treated with RTX (375 mg/m(2)) and IVIg (0.4 g/kg) for 4 days. The efficacy of R...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: An, Gun Hee, Yun, Jintak, Hong, Yu Ah, Khvan, Marina, Chung, Byung Ha, Choi, Bum Soon, Park, Cheol Whee, Choi, Yeong Jin, Kim, Yong-Soo, Yang, Chul Woo
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2014
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3987969/
https://ncbi.nlm.nih.gov/pubmed/24741626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/828732
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы